IVIEW Therapeutics has a total of 74 patents globally, out of which 28 have been granted. Of these 74 patents, more than 79% patents are active. United States of America is where IVIEW Therapeutics has filed the maximum number of patents, followed by China and Europe. Parallelly, China seems to be the main focused R&D centre and also United States of America is the origin country of IVIEW Therapeutics.
IVIEW Therapeutics was founded in the year 2015. The Company is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.
Do read about some of the most popular patents of IVIEW Therapeutics which have been covered by us in this article and also you can find IVIEW Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IVIEW Therapeutics patent portfolio.
How many patents does the founder and the CEO of IVIEW Therapeutics have?
The founder John J. Baldwin has 10 patents and CEO Bo Liang (also founder) has 0 patent.
How many patents does IVIEW Therapeutics have?
IVIEW Therapeutics has a total of 74 patents globally. These patents belong to 20 unique patent families. Out of 74 patents, 59 patents are active.
How Many Patents did IVIEW Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | IVIEW Therapeutics Applications Filed | IVIEW Therapeutics Patents Granted |
2023 | – | 3 |
2022 | 10 | 6 |
2021 | 6 | 7 |
2020 | 17 | 3 |
2019 | 2 | 1 |
2018 | 10 | 1 |
2017 | 2 | 2 |
2016 | 13 | 1 |
2015 | – | 1 |
2014 | 1 | – |
2013 | 4 | 3 |
2012 | 4 | – |
How many IVIEW Therapeutics patents are Alive/Dead?
How Many Patents did IVIEW Therapeutics File in Different Countries?
Countries in which IVIEW Therapeutics Filed Patents
Country | Patents |
United States Of America | 14 |
China | 13 |
Europe | 8 |
Canada | 6 |
Japan | 6 |
Australia | 3 |
Hong Kong (S.A.R.) | 3 |
Korea (South) | 2 |
Germany | 2 |
Israel | 2 |
India | 2 |
Austria | 1 |
Brazil | 1 |
Spain | 1 |
Where are Research Centres of IVIEW Therapeutics Patents Located?
10 Best IVIEW Therapeutics Patents
US20140219949A1 is the most popular patent in the IVIEW Therapeutics portfolio. It has received 17 citations so far from companies like Iview Therapeutics, Inc., Firebrick Pharma Limited and Veloce Biopharma Llc.
Below is the list of 10 most cited patents of IVIEW Therapeutics:
Publication Number | Citation Count |
US20140219949A1 | 17 |
WO2017074965A1 | 13 |
US10195217B2 | 5 |
US9895382B2 | 4 |
WO2021034421A1 | 4 |
US9308173B2 | 3 |
CN112516084A | 3 |
CN111939120A | 3 |
WO2019046844A1 | 2 |
WO2018004739A1 | 2 |
What Percentage of IVIEW Therapeutics US Patent Applications were Granted?
IVIEW Therapeutics (Excluding its subsidiaries) has filed 15 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 9 have been granted leading to a grant rate of 90.0%.
Below are the key stats of IVIEW Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for IVIEW Therapeutics?
Law Firm | Total Applications | Success Rate |
Venture Partner Llc | 11 | 100.00% |
Edward T Wei | 4 | 66.67% |
What are IVIEW Therapeutics key innovation segments?
What Technologies are Covered by IVIEW Therapeutics?
The chart below distributes patents filed by IVIEW Therapeutics